CID 16130391

Rev-10 oligonucleotide-cholesterol deriv.

Structural Information

Molecular Formula
C124H173N29O66P10
SMILES
CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)OC3CC(OC3COP(=O)(O)OC4CC(OC4COP(=O)(O)OC5CC(OC5COP(=O)(O)OC6CC(OC6COP(=O)(O)OC7CC(OC7COP(=O)(O)OC8CC(OC8COP(=O)(O)OC9CC(OC9COP(=O)(O)OC1CC(OC1COP(=O)(O)OC1CC(OC1COP(=O)(NCC(=O)OC1CCC2(C3CCC4(C(C3CC=C2C1)CCC4C(C)CCCC(C)C)C)C)O)N1C=CC(=NC1=O)N)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)N1C=CC(=NC1=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=CC(=NC1=O)N)N1C=C(C(=O)NC1=O)C)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)O
InChI
InChI=1S/C124H173N29O66P10/c1-58(2)11-10-12-59(3)67-15-16-68-66-14-13-64-31-65(17-24-123(64,8)69(66)18-25-124(67,68)9)200-105(155)42-132-220(170,171)190-48-81-71(33-96(202-81)144-26-19-90(125)133-114(144)161)211-222(174,175)196-53-86-76(38-101(207-86)150-44-61(5)109(157)141-120(150)167)216-227(184,185)194-51-84-73(35-98(205-84)146-28-21-92(127)135-116(146)163)213-223(176,177)192-50-83-75(37-100(204-83)148-30-23-94(129)137-118(148)165)215-225(180,181)199-56-89-79(41-104(210-89)153-57-131-106-107(153)138-113(130)139-112(106)160)219-229(188,189)195-52-85-74(36-99(206-85)147-29-22-93(128)136-117(147)164)214-224(178,179)197-54-87-78(40-103(208-87)152-46-63(7)111(159)143-122(152)169)218-228(186,187)198-55-88-77(39-102(209-88)151-45-62(6)110(158)142-121(151)168)217-226(182,183)193-49-82-72(34-97(203-82)145-27-20-91(126)134-115(145)162)212-221(172,173)191-47-80-70(154)32-95(201-80)149-43-60(4)108(156)140-119(149)166/h13,19-23,26-30,43-46,57-59,65-89,95-104,154H,10-12,14-18,24-25,31-42,47-56H2,1-9H3,(H,172,173)(H,174,175)(H,176,177)(H,178,179)(H,180,181)(H,182,183)(H,184,185)(H,186,187)(H,188,189)(H2,125,133,161)(H2,126,134,162)(H2,127,135,163)(H2,128,136,164)(H2,129,137,165)(H2,132,170,171)(H,140,156,166)(H,141,157,167)(H,142,158,168)(H,143,159,169)(H3,130,138,139,160)
InChIKey
KTDABVVHTIMVRU-UHFFFAOYSA-N
Compound name
[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(4-amino-2-oxopyrimidin-1-yl)-3-[[3-[[3-[[5-(4-amino-2-oxopyrimidin-1-yl)-3-[hydroxy-[[3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-N-[2-[[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-2-oxoethyl]phosphonamidic acid
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

3433.845 Da
Monoisotopic Mass

-12.2
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 3434.8523 294.8
[M+Na]+ 3456.8342 300.0
[M-H]- 3432.8377 298.0
[M+NH4]+ 3451.8788 296.9
[M+K]+ 3472.8082 296.4
[M+H-H2O]+ 3416.8423 293.0
[M+HCOO]- 3478.8432 296.9
[M+CH3COO]- 3492.8589 297.3
[M+Na-2H]- 3454.8197 305.9
[M]+ 3433.8445 295.2
[M]- 3433.8455 295.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.